ART reduces Alzheimer’s prevalence amongst sufferers with HIV

ART reduces Alzheimer’s prevalence among patients with HIV

October 08, 2020

2 min learn



Liu G, et al. Summary 537. Offered at: Annual Assembly of the American Neurological Affiliation. Oct. 4-9, 2020; digital.

Liu stories no related monetary disclosures.

We had been unable to course of your request. Please attempt once more later. In case you proceed to have this situation please contact

The prevalence of Alzheimer’s illness is elevated amongst sufferers with HIV, and the prevalence of early onset Alzheimer’s illness is even larger amongst sufferers who should not being handled with ART, examine findings confirmed.

Researchers additionally discovered that ART reduces the prevalence of Alzheimer’s illness amongst sufferers with HIV to the identical seen amongst sufferers with out HIV, in line with information introduced on the Annual Assembly of the American Neurological Affiliation.

HIV in gray
Though HIV might improve threat of Alzheimer’s illness (AD), these being handled with ART have related AD prevalence as those that are HIV damaging.
Credit score: Adobe Inventory

“The survivors of the early waves [of the HIV epidemic in the United States] are coming into seniorhood,” Guodong Liu, PhD, affiliate professor of public well being sciences and neurology, pediatrics, psychiatry and behavioral well being on the Penn State College School of Medication, informed Healio.

“Whereas we’ve already identified HIV is related to sure varieties of dementia completely different from Alzheimer’s illness it has been rumored, even hypothesized by some investigators, that HIV might improve the chance of AD. Nonetheless, no stable proof has but been discovered.”

Guodong Liu

Liu and colleagues used the MarketScan nationwide well being care claims database of privately insured people within the U.S. to evaluate the chance for early onset AD amongst sufferers with HIV aged 64 years or youthful.

They recognized 74,144 sufferers with HIV enrolled within the database for at the very least 1 12 months throughout the examine interval who had been aged at the very least 50 years throughout any level of the examine interval. In line with the examine, 44.3% didn’t obtain ART throughout the examine interval, and there was an elevated prevalence of AD amongst sufferers with HIV (0.11%) in contrast with these with out HIV (0.07%). The examine demonstrated that the prevalence of early-onset AD was even larger amongst these with out ART therapy (0.16%).

Moreover, it confirmed that the prevalence of AD amongst sufferers handled with ART was the identical as people with out HIV (0.07%).

In line with the researchers, an evaluation confirmed that HIV an infection was related to the next threat for early-onset AD (adjusted OR = 1.56; 95% CI, 1.24-1.97), whereas ART therapy was related to decrease AD threat (aOR = 0.50; CI, 0.30-0.81) after adjusting for coronary heart illness, hypertension, diabetes, age and gender amongst different demographic variables.

When it comes to how and why ART lowers the chance for AD, Liu mentioned they speculate that ART might cut back the neurological toxicity as a consequence of unsuppressed HIV virus, or that ART might cut back the prevalence of different medical situations that had been extremely prevalent amongst sufferers with HIV, together with hypertension, diabetes and excessive ldl cholesterol, that are threat elements for AD.

“It’s important for HIV sufferers to remain on or adhere to ART so to reduce the chance of AD as a consequence of HIV,” Liu mentioned.

You may also like

Leave a Reply

Your email address will not be published. Required fields are marked *